Compare Mutual Funds

Pros
5Y returns in the top 25% of the category.

5Y returns in the top 25% of the category.

3Y returns in the top 25% of the category.

3Y returns in the top 25% of the category.

Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

5Y returns in the top 25% of the category.

5Y returns in the top 25% of the category.

Among most bought funds within the category.

Among most bought funds within the category.

Larger AUM within category.

Larger AUM within category.

Cons

-

-

INDMoney rank
4/8
3/8
Category

Equity, Sector - Healthcare

Equity, Sector - Healthcare

Fund Age

13 Years 10 Months

8 Years 3 Months

Fund AUM

₹1371 Cr

₹6803 Cr

Min Investment
  1. SIP ₹500
  2. Lumpsum ₹5000
  1. SIP ₹100
  2. Lumpsum ₹5000
Expense Ratio

1.28%

1.33%

Exit Load

1%

1%

Benchmark Index

BSE Healthcare TR INR

BSE Healthcare TR INR

No of Holdings

46

38

Top 5 Holdings
  1. Sun Pharmaceuticals Industries Ltd(8.71%)
  2. Divi's Laboratories Ltd(5.57%)
  3. Ajanta Pharma Ltd(4.8%)
  4. Caplin Point Laboratories Ltd(3.95%)
  5. Lupin Ltd(3.59%)
  1. Sun Pharmaceuticals Industries Ltd(12.69%)
  2. Dr Reddy's Laboratories Ltd(8.45%)
  3. Cipla Ltd(6.56%)
  4. Divi's Laboratories Ltd(6.03%)
  5. Mankind Pharma Ltd(5.47%)
No of Sectors

1

2

Top 3 Sectors

Health

(100%)

  1. Health(98.79%)
  2. Basic Materials(1.21%)
Equity %

97.08%

97.16%

Debt %

-

-

P/E

40.78

38.49

P/B

5.72

4.35

Credit Quality

-

-

Modified Duration

-

-

YTM

-

-

1-Month Return

2.52%

-0.3%

3-Month Return

13.01%

6.61%

6-Month Return

21.94%

14.01%

1-Year Return

19.89%

10.78%

3-Year Return

25.28%

23.54%

5-Year Return

16.22%

16.01%

Sharpe

1.11

1.03

Alpha

1.79

1.05

Beta

0.96

0.95

Standard Deviation

15.93

16.12

Information Ratio

0.42

0.1

Description

UTI Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run.

ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Managers

Kamal Gada

Sharmila D’mello, Dharmesh Kakkad

Most Popular Comparisons